Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph Nodes
Pandemic live attenuated influenza vaccines (pLAIV) prime subjects for a robust neutralizing antibody response upon subsequent administration of a pandemic inactivated subunit vaccine (pISV). However, a difference was not detected in H5-specific memory B cells in the peripheral blood between pLAIV-p...
Uloženo v:
| Vydáno v: | Journal of virology Ročník 92; číslo 9 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
01.05.2018
|
| Témata: | |
| ISSN: | 1098-5514, 1098-5514 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Pandemic live attenuated influenza vaccines (pLAIV) prime subjects for a robust neutralizing antibody response upon subsequent administration of a pandemic inactivated subunit vaccine (pISV). However, a difference was not detected in H5-specific memory B cells in the peripheral blood between pLAIV-primed and unprimed subjects prior to pISV boost. To investigate the mechanism underlying pLAIV priming, we vaccinated groups of 12 African green monkeys (AGMs) with H5N1 pISV or pLAIV alone or H5N1 pLAIV followed by pISV and examined immunity systemically and in local draining lymph nodes (LN). The AGM model recapitulated the serologic observations from clinical studies. Interestingly, H5N1 pLAIV induced robust germinal center B cell responses in the mediastinal LN (MLN). Subsequent boosting with H5N1 pISV drove increases in H5-specific B cells in the axillary LN, spleen, and circulation in H5N1 pLAIV-primed animals. Thus, H5N1 pLAIV primes localized B cell responses in the MLN that are recalled systemically following pISV boost. These data provide mechanistic insights for the generation of robust humoral responses via prime-boost vaccination.
We have previously shown that pandemic live attenuated influenza vaccines (pLAIV) prime for a rapid and robust antibody response on subsequent administration of inactivated subunit vaccine (pISV). This is observed even in individuals who had undetectable antibody (Ab) responses following the initial vaccination. To define the mechanistic basis of pLAIV priming, we turned to a nonhuman primate model and performed a detailed analysis of B cell responses in systemic and local lymphoid tissues following prime-boost vaccination with pLAIV and pISV. We show that the nonhuman primate model recapitulates the serologic observations from clinical studies. Further, we found that pLAIVs induced robust germinal center B cell responses in the mediastinal lymph node. Subsequent boosting with pISV in pLAIV-primed animals resulted in detection of B cells in the axillary lymph nodes, spleen, and peripheral blood. We demonstrate that intranasally administered pLAIV elicits a highly localized germinal center B cell response in the mediastinal lymph node that is rapidly recalled following pISV boost into germinal center reactions at numerous distant immune sites. |
|---|---|
| AbstractList | Pandemic live attenuated influenza vaccines (pLAIV) prime subjects for a robust neutralizing antibody response upon subsequent administration of a pandemic inactivated subunit vaccine (pISV). However, a difference was not detected in H5-specific memory B cells in the peripheral blood between pLAIV-primed and unprimed subjects prior to pISV boost. To investigate the mechanism underlying pLAIV priming, we vaccinated groups of 12 African green monkeys (AGMs) with H5N1 pISV or pLAIV alone or H5N1 pLAIV followed by pISV and examined immunity systemically and in local draining lymph nodes (LN). The AGM model recapitulated the serologic observations from clinical studies. Interestingly, H5N1 pLAIV induced robust germinal center B cell responses in the mediastinal LN (MLN). Subsequent boosting with H5N1 pISV drove increases in H5-specific B cells in the axillary LN, spleen, and circulation in H5N1 pLAIV-primed animals. Thus, H5N1 pLAIV primes localized B cell responses in the MLN that are recalled systemically following pISV boost. These data provide mechanistic insights for the generation of robust humoral responses via prime-boost vaccination.IMPORTANCE We have previously shown that pandemic live attenuated influenza vaccines (pLAIV) prime for a rapid and robust antibody response on subsequent administration of inactivated subunit vaccine (pISV). This is observed even in individuals who had undetectable antibody (Ab) responses following the initial vaccination. To define the mechanistic basis of pLAIV priming, we turned to a nonhuman primate model and performed a detailed analysis of B cell responses in systemic and local lymphoid tissues following prime-boost vaccination with pLAIV and pISV. We show that the nonhuman primate model recapitulates the serologic observations from clinical studies. Further, we found that pLAIVs induced robust germinal center B cell responses in the mediastinal lymph node. Subsequent boosting with pISV in pLAIV-primed animals resulted in detection of B cells in the axillary lymph nodes, spleen, and peripheral blood. We demonstrate that intranasally administered pLAIV elicits a highly localized germinal center B cell response in the mediastinal lymph node that is rapidly recalled following pISV boost into germinal center reactions at numerous distant immune sites.Pandemic live attenuated influenza vaccines (pLAIV) prime subjects for a robust neutralizing antibody response upon subsequent administration of a pandemic inactivated subunit vaccine (pISV). However, a difference was not detected in H5-specific memory B cells in the peripheral blood between pLAIV-primed and unprimed subjects prior to pISV boost. To investigate the mechanism underlying pLAIV priming, we vaccinated groups of 12 African green monkeys (AGMs) with H5N1 pISV or pLAIV alone or H5N1 pLAIV followed by pISV and examined immunity systemically and in local draining lymph nodes (LN). The AGM model recapitulated the serologic observations from clinical studies. Interestingly, H5N1 pLAIV induced robust germinal center B cell responses in the mediastinal LN (MLN). Subsequent boosting with H5N1 pISV drove increases in H5-specific B cells in the axillary LN, spleen, and circulation in H5N1 pLAIV-primed animals. Thus, H5N1 pLAIV primes localized B cell responses in the MLN that are recalled systemically following pISV boost. These data provide mechanistic insights for the generation of robust humoral responses via prime-boost vaccination.IMPORTANCE We have previously shown that pandemic live attenuated influenza vaccines (pLAIV) prime for a rapid and robust antibody response on subsequent administration of inactivated subunit vaccine (pISV). This is observed even in individuals who had undetectable antibody (Ab) responses following the initial vaccination. To define the mechanistic basis of pLAIV priming, we turned to a nonhuman primate model and performed a detailed analysis of B cell responses in systemic and local lymphoid tissues following prime-boost vaccination with pLAIV and pISV. We show that the nonhuman primate model recapitulates the serologic observations from clinical studies. Further, we found that pLAIVs induced robust germinal center B cell responses in the mediastinal lymph node. Subsequent boosting with pISV in pLAIV-primed animals resulted in detection of B cells in the axillary lymph nodes, spleen, and peripheral blood. We demonstrate that intranasally administered pLAIV elicits a highly localized germinal center B cell response in the mediastinal lymph node that is rapidly recalled following pISV boost into germinal center reactions at numerous distant immune sites. Pandemic live attenuated influenza vaccines (pLAIV) prime subjects for a robust neutralizing antibody response upon subsequent administration of a pandemic inactivated subunit vaccine (pISV). However, a difference was not detected in H5-specific memory B cells in the peripheral blood between pLAIV-primed and unprimed subjects prior to pISV boost. To investigate the mechanism underlying pLAIV priming, we vaccinated groups of 12 African green monkeys (AGMs) with H5N1 pISV or pLAIV alone or H5N1 pLAIV followed by pISV and examined immunity systemically and in local draining lymph nodes (LN). The AGM model recapitulated the serologic observations from clinical studies. Interestingly, H5N1 pLAIV induced robust germinal center B cell responses in the mediastinal LN (MLN). Subsequent boosting with H5N1 pISV drove increases in H5-specific B cells in the axillary LN, spleen, and circulation in H5N1 pLAIV-primed animals. Thus, H5N1 pLAIV primes localized B cell responses in the MLN that are recalled systemically following pISV boost. These data provide mechanistic insights for the generation of robust humoral responses via prime-boost vaccination. We have previously shown that pandemic live attenuated influenza vaccines (pLAIV) prime for a rapid and robust antibody response on subsequent administration of inactivated subunit vaccine (pISV). This is observed even in individuals who had undetectable antibody (Ab) responses following the initial vaccination. To define the mechanistic basis of pLAIV priming, we turned to a nonhuman primate model and performed a detailed analysis of B cell responses in systemic and local lymphoid tissues following prime-boost vaccination with pLAIV and pISV. We show that the nonhuman primate model recapitulates the serologic observations from clinical studies. Further, we found that pLAIVs induced robust germinal center B cell responses in the mediastinal lymph node. Subsequent boosting with pISV in pLAIV-primed animals resulted in detection of B cells in the axillary lymph nodes, spleen, and peripheral blood. We demonstrate that intranasally administered pLAIV elicits a highly localized germinal center B cell response in the mediastinal lymph node that is rapidly recalled following pISV boost into germinal center reactions at numerous distant immune sites. |
| Author | Andrews, Sarah F Santos, Celia P Hickman, Heather D Talaat, Kawsar R Subbarao, Kanta Matsuoka, Yumiko Permar, Sallie R Brenchley, Jason M Roederer, Mario Yewdell, Jonathan W Jegaskanda, Sinthujan Reynoso, Glennys V McDermott, Adrian B Zhang, Ruijun Luke, Catherine J Koup, Richard A Ambrozak, David R Wheatley, Adam K Liao, Hua-Xin Mason, Rosemarie D |
| Author_xml | – sequence: 1 givenname: Sinthujan surname: Jegaskanda fullname: Jegaskanda, Sinthujan organization: Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia – sequence: 2 givenname: Rosemarie D surname: Mason fullname: Mason, Rosemarie D organization: Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA – sequence: 3 givenname: Sarah F surname: Andrews fullname: Andrews, Sarah F organization: Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA – sequence: 4 givenname: Adam K orcidid: 0000-0002-5593-9387 surname: Wheatley fullname: Wheatley, Adam K organization: Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia – sequence: 5 givenname: Ruijun surname: Zhang fullname: Zhang, Ruijun organization: Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA – sequence: 6 givenname: Glennys V surname: Reynoso fullname: Reynoso, Glennys V organization: Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA – sequence: 7 givenname: David R surname: Ambrozak fullname: Ambrozak, David R organization: Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA – sequence: 8 givenname: Celia P surname: Santos fullname: Santos, Celia P organization: Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA – sequence: 9 givenname: Catherine J surname: Luke fullname: Luke, Catherine J organization: Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA – sequence: 10 givenname: Yumiko surname: Matsuoka fullname: Matsuoka, Yumiko organization: Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA – sequence: 11 givenname: Jason M surname: Brenchley fullname: Brenchley, Jason M organization: Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA – sequence: 12 givenname: Heather D surname: Hickman fullname: Hickman, Heather D organization: Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA – sequence: 13 givenname: Kawsar R surname: Talaat fullname: Talaat, Kawsar R organization: Center for Immunization Research, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA – sequence: 14 givenname: Sallie R surname: Permar fullname: Permar, Sallie R organization: Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA – sequence: 15 givenname: Hua-Xin surname: Liao fullname: Liao, Hua-Xin organization: Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA – sequence: 16 givenname: Jonathan W surname: Yewdell fullname: Yewdell, Jonathan W organization: Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA – sequence: 17 givenname: Richard A surname: Koup fullname: Koup, Richard A organization: Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA – sequence: 18 givenname: Mario surname: Roederer fullname: Roederer, Mario organization: Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA – sequence: 19 givenname: Adrian B surname: McDermott fullname: McDermott, Adrian B email: adrian.mcdermott@nih.gov, ksubbarao@niaid.nih.gov organization: Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA adrian.mcdermott@nih.gov ksubbarao@niaid.nih.gov – sequence: 20 givenname: Kanta orcidid: 0000-0003-1713-3056 surname: Subbarao fullname: Subbarao, Kanta email: adrian.mcdermott@nih.gov, ksubbarao@niaid.nih.gov organization: Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA adrian.mcdermott@nih.gov ksubbarao@niaid.nih.gov |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29444938$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNUEtPwzAYi9AQe8CNM8qRS0eSpl17hGmDovIQgl2rL-nXEdSmpWmRtl9PEUPiZMuyLNtTMrK1RULOOZtzLqKr-00yZzxeMI8vjsiEszjygoDL0T8-JlPnPhjjUobyhIxFLKWM_WhCtontWrDgoKSp-UKa2KLs0e6BbkBrY5E-t6YydktXpdGmczStNZRmjzm9oUssS_qCrqmtQ0eNpQ-YG3CdsT-Bu6p5p491ju6UHBdQOjw74Iy8rVevyzsvfbpNltepp2XAOk9hzoUWKpSgAihCHwYhRGCB5FwBVyoMdbFAxELEhR-jiqTP88JnOmB-DmJGLn9zm7b-7NF1WWWcHlqCxbp3mWBMyMgXIRusFwdrryrMs2bYCe0u-ztHfAPD0mjk |
| CitedBy_id | crossref_primary_10_3390_vaccines10111826 crossref_primary_10_3390_vaccines9010024 crossref_primary_10_4049_jimmunol_1801070 crossref_primary_10_4049_jimmunol_1900157 crossref_primary_10_3390_vaccines7040133 crossref_primary_10_1111_imcb_12383 crossref_primary_10_1080_14760584_2024_2331065 crossref_primary_10_3390_vaccines8010036 crossref_primary_10_3390_v12090968 crossref_primary_10_1208_s12249_022_02330_9 crossref_primary_10_1016_j_coi_2018_06_004 crossref_primary_10_1016_j_vaccine_2022_03_051 crossref_primary_10_1038_s41590_022_01345_5 crossref_primary_10_3389_fimmu_2019_01787 crossref_primary_10_3390_vaccines8030434 crossref_primary_10_3389_fimmu_2019_00756 crossref_primary_10_1172_JCI123366 crossref_primary_10_1007_s40265_018_0958_7 crossref_primary_10_1186_s12979_019_0167_6 crossref_primary_10_1038_s41590_022_01359_z crossref_primary_10_1007_s00103_019_02921_1 crossref_primary_10_1016_S1473_3099_19_30393_7 crossref_primary_10_3390_pathogens8040167 |
| ContentType | Journal Article |
| Copyright | Copyright © 2018 American Society for Microbiology. |
| Copyright_xml | – notice: Copyright © 2018 American Society for Microbiology. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1128/JVI.01970-17 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1098-5514 |
| ExternalDocumentID | 29444938 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Intramural |
| GroupedDBID | --- -~X 0R~ 18M 29L 2WC 39C 4.4 53G 5GY 5RE 5VS 85S ABPPZ ACGFO ACNCT ADBBV AENEX AGVNZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW CGR CS3 CUY CVF DIK E3Z EBS ECM EIF EJD F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 N9A NPM O9- OK1 P2P RHI RNS RPM RSF TR2 UPT W2D W8F WH7 WOQ YQT ~02 ~KM 7X8 AAFWJ AAGFI |
| ID | FETCH-LOGICAL-c450t-bed12c2b64ab5af63aed16ea05411ba1bb66cf7eeef29f39eb8431df30c503da2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 32 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000430281200021&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1098-5514 |
| IngestDate | Thu Oct 02 11:46:47 EDT 2025 Thu Apr 03 07:05:45 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Keywords | influenza LAIV B cells vaccines |
| Language | English |
| License | Copyright © 2018 American Society for Microbiology. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c450t-bed12c2b64ab5af63aed16ea05411ba1bb66cf7eeef29f39eb8431df30c503da2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0003-1713-3056 0000-0002-5593-9387 |
| OpenAccessLink | https://jvi.asm.org/content/jvi/92/9/e01970-17.full.pdf |
| PMID | 29444938 |
| PQID | 2002483260 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2002483260 pubmed_primary_29444938 |
| PublicationCentury | 2000 |
| PublicationDate | 2018-05-01 |
| PublicationDateYYYYMMDD | 2018-05-01 |
| PublicationDate_xml | – month: 05 year: 2018 text: 2018-05-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Journal of virology |
| PublicationTitleAlternate | J Virol |
| PublicationYear | 2018 |
| SSID | ssj0014464 |
| Score | 2.4162276 |
| Snippet | Pandemic live attenuated influenza vaccines (pLAIV) prime subjects for a robust neutralizing antibody response upon subsequent administration of a pandemic... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| SubjectTerms | Administration, Intranasal Animals Antibodies, Neutralizing - blood Antibodies, Neutralizing - immunology Antibodies, Viral - blood Antibodies, Viral - immunology B-Lymphocytes - immunology Cercopithecus aethiops Female Humans Influenza A Virus, H5N1 Subtype - immunology Influenza Vaccines - immunology Influenza, Human - prevention & control Lymph Nodes - cytology Lymph Nodes - immunology Lymphocyte Count Male Vaccination Vaccines, Attenuated - immunology Vaccines, Subunit - immunology |
| Title | Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph Nodes |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/29444938 https://www.proquest.com/docview/2002483260 |
| Volume | 92 |
| WOSCitedRecordID | wos000430281200021&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NS8MwFA_qFLz4_TG_iOC12iZp2p5Ex4aTOYbo2K0kaTIKo512Cttf70vbsYsHwUsPpSEleXnvl_d7vB9CN4YFTAvGHekZBhcUEzlRyKijbH8xEirGy2r3YS_o98PRKBrUCbeiLqtc-sTSUSe5sjnyO1J23wKw4d5PPxyrGmXZ1VpCYx01KEAZa9XBaMUiwFWnZJVtz0yLDJaF7yS8ex52bwHdBK5TS5X9Ci7LINPZ_e_v7aGdGl7ih8oe9tGazg7QViU4OT9E467N5WaigG964Odwt9IoWQg8FMpy7HhQ6nyNcXuSqnRW4J4NdulCJ_gRt_Rkgl-rqlpd4DTDlucR4CXspL05WAbu54kujtB7p_3WenJqqQVHMd-dOVInHlFEciakLwynAl5wLQDQeZ4UnpScKxNorQ2JDI20hA31EkNd5bs0EeQYbWR5pk8Rpoa7AUR97srEooNQKt9PFDWacleEpImulysYgylbfkJkOv8q4tUaNtFJtQ3xtOq5EZOIMRbR8OwPo8_RNsCasCpLvEANAwdZX6JN9T1Li8-r0kbg2R-8_ABaf8Zn |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intranasal+Live+Influenza+Vaccine+Priming+Elicits+Localized+B+Cell+Responses+in+Mediastinal+Lymph+Nodes&rft.jtitle=Journal+of+virology&rft.au=Jegaskanda%2C+Sinthujan&rft.au=Mason%2C+Rosemarie+D&rft.au=Andrews%2C+Sarah+F&rft.au=Wheatley%2C+Adam+K&rft.date=2018-05-01&rft.issn=1098-5514&rft.eissn=1098-5514&rft.volume=92&rft.issue=9&rft_id=info:doi/10.1128%2FJVI.01970-17&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1098-5514&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1098-5514&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1098-5514&client=summon |